Invention Grant
- Patent Title: Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
- Patent Title (中): 用于治疗退行性和炎性疾病的吡唑嗪化合物
-
Application No.: US12151586Application Date: 2008-05-07
-
Publication No.: US08133895B2Publication Date: 2012-03-13
- Inventor: Martin James Inglis Andrews , Mark Stuart Chambers , Wolfgang Schmidt , Grégory Louis Joseph Bar
- Applicant: Martin James Inglis Andrews , Mark Stuart Chambers , Wolfgang Schmidt , Grégory Louis Joseph Bar
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica N.V.
- Current Assignee: Janssen Pharmaceutica N.V.
- Current Assignee Address: BE Beerse
- Agency: Woodcock Washburn LLP
- Main IPC: A61K31/4965
- IPC: A61K31/4965
Abstract:
Novel fused pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammation, rheumatoid arthritis and others.
Public/Granted literature
- US20090131446A1 Fused pyrazine compounds useful for the treatment of degenerative and inflmmatory diseases Public/Granted day:2009-05-21
Information query
